🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "targeted measures to address cost of living pressures" in the forthcoming Budget.

During an interview with the BBC, she emphasized that lowering inflation is a shared duty of both the government and the central bank.

The United Kingdom's inflation rate is projected to be the most elevated among the Group of Seven advanced economies this year and next.

Potential Utility Cost Measures

Sources suggest the government could take action to lower utility costs, such as by cutting the present 5% rate of VAT applied on energy.

A further option is to cut some of the policy costs presently added to bills.

Budgetary Constraints and Expert Predictions

The government will receive the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for such actions.

The view from most experts is that the Chancellor will have to announce higher taxes or spending cuts in order to adhere to her declared debt limits.

Earlier on the same day, estimates suggested there was a £22 billion shortfall for the Treasury chief to address, which is at the lower end of projections.

"It is a collective job between the central bank and the administration to continue tackling some of the sources of price increases," the Chancellor informed the BBC in Washington, at the conferences of the IMF and World Bank.

Revenue Commitments and Global Issues

While much of the focus has been on likely tax rises, the Treasury chief said the most recent data from the fiscal watchdog had not altered her vow to election pledges not to raise rates on earnings tax, VAT or social security contributions.

She attributed an "uncertain global environment" with growing geopolitical and trade concerns for the Budget revenue measures, probably to be focused on those "most able to pay."

International Trade Tensions

Commenting on apprehensions about the UK's trade ties with the Asian nation she said: "The UK's security interests invariably are paramount."

Recent declaration by Chinese authorities to strengthen trade restrictions on rare earths and other resources that are essential for high-technology production led American leader Donald Trump to suggest an further 100% tariff on imports from the Asian country, raising the risk of an all-out trade war between the two global powers.

The US Treasury Secretary called China's action "commercial pressure" and "a international production control attempt."

Questioned on accepting the US offer to participate in its battle with China, the Chancellor said she was "very concerned" by Chinese measures and called on the Chinese government "not to put up barriers and limit trade."

She said the action was "damaging for the world economy and causes further obstacles."

"I believe there are sectors where we need to address China, but there are also valuable opportunities to trade with Chinese markets, including banking sector and other areas of the economic system. We've got to get that equilibrium correct."

The chancellor also confirmed she was collaborating with other major economies "regarding our own essential resources strategy, so that we are more independent."

Health Service Medicine Costs and Investment

The Chancellor also acknowledged that the cost the NHS spends on drugs could increase as a result of current talks with the US government and its pharmaceutical firms, in exchange for reduced taxes and investment.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either halting or canceling operations in the UK, with several attributing the modest returns they are obtaining.

Recently, the Science Minister said the price the health service pays for medicines would have to rise to halt firms and pharmaceutical investment leaving the United Kingdom.

The Chancellor stated to media: "We have seen due to the pricing regime, that drug testing, new drugs have not been offered in the United Kingdom in the manner that they are in other EU nations."

"The objective is to ensure that patients receiving care from the National Health Service are can access the finest critical drugs in the globe. And so we are examining this situation, and... looking to obtain more capital into the UK."